Low doses of subcutaneous interleukin-2 plus interferon-α do not induce thyroid function alterations in advanced renal cell carcinoma patients
Keyword(s):
1999 ◽
Vol 22
(2)
◽
pp. 156-161
◽
Keyword(s):
1994 ◽
Vol 30
(4)
◽
pp. 530-532
◽
2002 ◽
Vol 7
(2)
◽
pp. 83
Keyword(s):
Keyword(s):